The Board meeting is scheduled for Saturday, May 30, 2026. The agenda includes two key items:
1. Approval of Audited Financial Results of the Company for both the half year and financial year ended March 31, 2026.
2. Consideration and recommendation of final dividend, if any, on the Equity Shares of the Company for the financial year ended March 31, 2026. Any dividend recommendation would be subject to approval by shareholders at the ensuing Annual General Meeting.
The company also confirmed that the Trading Window for dealing in the company's securities has been closed since April 1, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's Insider Trading Policy. The trading window closure applies to all Designated Persons, their relatives, and Insiders as defined in the policy. The trading window will reopen 48 hours after the announcement of the Audited Financial Results.
This disclosure references the company's earlier intimation dated March 26, 2026, regarding the trading window closure. The information will also be made available on the company's website at www.amwillhealthcare.com.
The communication was signed by ANSHU ANSHUMAN, Company Secretary and Compliance Officer (ACS:65515), from Bangalore on May 26, 2026, at 16:51:36 IST.